Related Experiment Video
Updated: May 22, 2026
07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Radiotherapy for head and neck cancer
1Department of Radiation Oncology, E-Da Hospital, Kaohsiung, Taiwan.
Seminars in Plastic Surgery
|May 3, 2012
Summary
Head and neck cancer treatment involves a team approach, often using radiotherapy. Advanced techniques like intensity-modulated radiotherapy improve precision and reduce side effects, enhancing patient quality of life.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Head and neck cancer management necessitates a multidisciplinary strategy.
- Radiotherapy is a cornerstone treatment, used either primarily or adjunctively with surgery.
- Treatment decisions are site-specific, influencing radiotherapy techniques, dosage, and fractionation.
Purpose of the Study:
- To review the role of radiotherapy in head and neck cancer.
- To highlight the impact of radiation-related complications on quality of life.
- To discuss modern radiotherapy techniques and future directions.
Main Methods:
- Literature review of radiotherapy in head and neck cancer.
- Analysis of treatment techniques and their impact on outcomes.
- Discussion of quality of life considerations and complications.
Main Results:
- Radiotherapy techniques are tailored to specific head and neck cancer subsites.
- Radiation-induced complications significantly affect patient quality of life.
- Advanced techniques like intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) enable precise delivery, sparing normal tissues.
Conclusions:
- Modern radiotherapy techniques offer improved precision and reduced toxicity in head and neck cancer treatment.
- Minimizing radiation-related complications is crucial for maintaining patient quality of life.
- Further research into novel strategies is essential for advancing head and neck cancer treatment outcomes.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...